BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38750439)

  • 1. Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.
    Petagna CN; Perez S; Hsu E; Greene BM; Banner I; Bednarczyk RA; Escoffery C
    BMC Cancer; 2024 May; 24(1):592. PubMed ID: 38750439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.
    Petagna CN; Perez S; Hsu E; Greene BM; Banner I; Bednarczyk RA; Escoffery C
    Res Sq; 2024 Mar; ():. PubMed ID: 38496559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
    Lim ASE; Lim RBT
    Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
    Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
    Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
    Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
    Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
    Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits, challenges, and strategies related to using presumptive recommendations for HPV vaccination: A qualitative study with rural and non-rural-serving primary care professionals.
    Odebunmi OO; Spees LP; Biddell CB; Yemeke T; Yanguela J; Higgins C; Gilkey M; Ozawa S; Wheeler SB
    Hum Vaccin Immunother; 2024 Dec; 20(1):2347018. PubMed ID: 38708779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers' perspectives.
    Vu M; King AR; Jang HM; Bednarczyk RA
    Health Educ Res; 2020 Dec; 35(6):512-523. PubMed ID: 32879948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.
    Dilley SE; Peral S; Straughn JM; Scarinci IC
    Prev Med; 2018 Aug; 113():124-131. PubMed ID: 29800594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.
    Boyd ED; Phillips JM; Schoenberger YM; Simpson T
    Vaccine; 2018 Jun; 36(28):4126-4133. PubMed ID: 29793895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
    Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
    BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short report: parents HPV vaccine knowledge in rural South Florida.
    Thomas TL; Caldera M; Maurer J
    Hum Vaccin Immunother; 2019; 15(7-8):1666-1671. PubMed ID: 30994388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9-14 years in rural communities of Northwest Cameroon: a qualitative study.
    Elit L; Ngalla C; Afugchwi GM; Tum E; Fokom Domgue J; Nouvet E
    BMJ Open; 2022 Nov; 12(11):e068212. PubMed ID: 36379650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Facilitators of HPV Vaccination in the VFC Program.
    Fleming WS; Sznajder KK; Nepps M; Boktor SW
    J Community Health; 2018 Jun; 43(3):448-454. PubMed ID: 29299729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and public health professionals' perceived facilitators and barriers of human papillomavirus (HPV) vaccination among African American adolescents in Shelby County, Tennessee.
    Jin SW; Lattimore DC; Harlin E; Davis L; Erholtz V; Brandt HM
    BMC Health Serv Res; 2023 May; 23(1):469. PubMed ID: 37165427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care providers' perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky.
    Head KJ; Vanderpool RC; Mills LA
    Public Health Nurs; 2013 Jul; 30(4):351-60. PubMed ID: 23808860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study.
    Chan DNS; Lee PPK; So WKW
    J Racial Ethn Health Disparities; 2024 Jun; 11(3):1465-1477. PubMed ID: 37195592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinician and Parent Perspectives on Educational Needs for Increasing Adolescent HPV Vaccination.
    Widman CA; Rodriguez EM; Saad-Harfouche F; Twarozek AM; Erwin DO; Mahoney MC
    J Cancer Educ; 2018 Apr; 33(2):332-339. PubMed ID: 27640203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.